Fig. 4

Exploratory analysis of ABC-Core in participants with less severe symptoms at baseline (ADOS 6–7) treated with 10 mg/kg or placebo
Exploratory analysis of ABC-Core in participants with less severe symptoms at baseline (ADOS 6–7) treated with 10 mg/kg or placebo